NCT05920252 is a NA clinical trial of Vira in Suicide, sponsored by Ksana Health.

Who is sponsoring NCT05920252?

NCT05920252 is sponsored by Ksana Health.

What drugs are being tested in NCT05920252?

Interventions in NCT05920252: Vira, Treatment as Usual (TAU).

What condition does NCT05920252 study?

NCT05920252 studies Suicide, Mental Health Disorder, Anhedonia.

Is NCT05920252 still recruiting?

NCT05920252 is currently recruiting now. Last updated 4 March 2026.

Last reviewed 2026-03-04 · How we verify

NCT05920252

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Digitally Assisted Risk Reduction Platform for Youth at High Risk for Suicide

Recruiting now NA Last updated 4 March 2026

What this trial tests

NA trial testing Vira in Suicide in 78 participants. Currently enrolling.

Timeline

14 August 2024

Primary endpoint
31 December 2026

31 December 2026

Quick facts

Lead sponsor	Ksana Health
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	78
Start date	14 August 2024
Primary completion	31 December 2026
Estimated completion	31 December 2026
Sites	1 location across United States

Drugs / interventions tested

Vira
Treatment as Usual (TAU) — full drug profile →

Conditions studied

Suicide — all drugs for Suicide →
Mental Health Disorder — all drugs for Mental Health Disorder →
Anhedonia — all drugs for Anhedonia →

Sponsor

Ksana Health — full company profile →

Who can join

Adults 13 to 18, any sex, with Suicide or Mental Health Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Despite efforts to prevent suicide, US rates are climbing, and suicide is the second leading cause of death among youth. Digital tools, especially personal smartphones, are promising avenues to address these issues and can be used to provide a unique understanding of risk factors, including psychological distress, anhedonia and behavioral withdrawal, and sleep disturbance among high-risk individuals. This project aims to enhance the effectiveness of the delivery of preventative health care to youth at risk for suicide by developing a comprehensive digital platform that allows practitioners to integrate mobile sensing data and HIPAA-compliant client communication tools into their management of these young people.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Study Preregistration: Testing a Digital Suicide Risk Reduction Platform for Adolescents: A Pragmatic Randomized Controlled Trial.
Funkhouser CJ, Tse TC, Weiner LS, deLuise D, et al · · 2024 · cited 4× · PMID 39069372 · DOI 10.1016/j.jaac.2024.03.012

Verify or expand the search:

Other recruiting trials for Suicide

Currently open trials in the same condition.

NCT07404787 — Evaluation of a Telehealth Case Management Intervention to Prevent Suicide Among Soldiers Discharged From Psychiatric Ho · NA · recruiting
NCT07214233 — Youth Empowerment and Safety Intervention · NA · recruiting
NCT07343258 — Pilot Study on Follow-Up of (Acutely) Suicidal Individuals From the Flemish Suicide Helpline · NA · recruiting
NCT07523490 — Investigation on Suicide Risk Factors of Patients With Mood Disorders · recruiting
NCT06571916 — Brief Skills for Safer Living (Brief-SfSL) · NA · recruiting

Other Ksana Health trials

Trials by the same sponsor.

NCT07348666 — A Just-in-time Adaptive Intervention for Suicide Safety Planning in Adolescents · NA · not yet recruiting
NCT06665620 — Optimizing a Just-in-time Adaptive Intervention for Suicide Safety Planning in Adolescents · NA · active not recruiting
NCT05638516 — Improving Mental Health in Youth and Lowering Risk for Obesity Through a Digital Preventative Product · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05920252 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ksana Health
Last refreshed: 4 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05920252.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing